TY - JOUR
T1 - Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome
T2 - First report of the IAIHG retrospective registry
AU - Slooter, Charlotte D.
AU - Van Den Brand, Floris F.
AU - Lleo, Ana
AU - Colapietro, Francesca
AU - Lenzi, Marco
AU - Muratori, Paolo
AU - Kerkar, Nanda
AU - Dalekos, George N.
AU - Zachou, Kalliopi
AU - Lucena, M. Isabel
AU - Robles-Díaz, Mercedes
AU - Di Zeo-Sánchez, Daniel E.
AU - Andrade, Raúl J.
AU - Montano-Loza, Aldo J.
AU - Lytvyak, Ellina
AU - Lissenberg-Witte, Birgit I.
AU - Maisonneuve, Patrick
AU - Bouma, Gerd
AU - MacEdo, Guilherme
AU - Liberal, Rodrigo
AU - De Boer, Ynto S.
AU - Dutch AIH Study Group
AU - International Autoimmune Hepatitis Group
AU - Gevers, Tom
N1 - Funding Information:
Ana Lleo received research grants from the Italian Foundation for Cancer Research (AIRC) and the Italian Ministry of Health. The International Autoimmune Hepatitis Group (IAIHG) retrospective registry was funded by the United European Gastroenterology LINK award (2015).
Publisher Copyright:
© 2023 American Association for the Study of Liver Diseases.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Background and Aims: The International Autoimmune Hepatitis Group retrospective registry (IAIHG-RR) is a web-based platform with subjects enrolled with a clinical diagnosis of autoimmune hepatitis (AIH). As prognostic factor studies with enough power are scarce, this study aimed to ascertain data quality and identify prognostic factors in the IAIHG-RR cohort. Methods: This retrospective, observational, multicenter study included all patients with a clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external validation of completeness and consistency for 29 predefined variables. Cox regression was used to identify risk factors for liver-related death and liver transplantation (LT). Results: This analysis included 2559 patients across 7 countries. In 1700 patients, follow-up was available, with a completeness of individual data of 90% (range: 30-100). During a median follow-up period of 10 (range: 0-49) years, there were 229 deaths, of which 116 were liver-related, and 143 patients underwent LT. Non-White ethnicity (HR 4.1 95% CI: 2.3-7.1), cirrhosis (HR 3.5 95% CI: 2.3-5.5), variant syndrome with primary sclerosing cholangitis (PSC) (HR 3.1 95% CI: 1.6-6.2), and lack of complete biochemical response within 6 months (HR 5.7 95% CI: 3.4-9.6) were independent prognostic factors. Conclusions: The IAIHG-RR represents the world's largest AIH cohort with moderate-to-good data quality and a relevant number of liver-related events. The registry is a suitable platform for patient selection in future studies. Lack of complete biochemical response to treatment, non-White ethnicity, cirrhosis, and PSC-AIH were associated with liver-related death and LT.
AB - Background and Aims: The International Autoimmune Hepatitis Group retrospective registry (IAIHG-RR) is a web-based platform with subjects enrolled with a clinical diagnosis of autoimmune hepatitis (AIH). As prognostic factor studies with enough power are scarce, this study aimed to ascertain data quality and identify prognostic factors in the IAIHG-RR cohort. Methods: This retrospective, observational, multicenter study included all patients with a clinical diagnosis of AIH from the IAIHG-RR. The quality assessment consisted of external validation of completeness and consistency for 29 predefined variables. Cox regression was used to identify risk factors for liver-related death and liver transplantation (LT). Results: This analysis included 2559 patients across 7 countries. In 1700 patients, follow-up was available, with a completeness of individual data of 90% (range: 30-100). During a median follow-up period of 10 (range: 0-49) years, there were 229 deaths, of which 116 were liver-related, and 143 patients underwent LT. Non-White ethnicity (HR 4.1 95% CI: 2.3-7.1), cirrhosis (HR 3.5 95% CI: 2.3-5.5), variant syndrome with primary sclerosing cholangitis (PSC) (HR 3.1 95% CI: 1.6-6.2), and lack of complete biochemical response within 6 months (HR 5.7 95% CI: 3.4-9.6) were independent prognostic factors. Conclusions: The IAIHG-RR represents the world's largest AIH cohort with moderate-to-good data quality and a relevant number of liver-related events. The registry is a suitable platform for patient selection in future studies. Lack of complete biochemical response to treatment, non-White ethnicity, cirrhosis, and PSC-AIH were associated with liver-related death and LT.
U2 - 10.1097/HEP.0000000000000589
DO - 10.1097/HEP.0000000000000589
M3 - Article
SN - 0270-9139
VL - 79
SP - 538
EP - 550
JO - Hepatology
JF - Hepatology
IS - 3
ER -